NCT04451863View on ClinicalTrials.gov

Analgesic and Subjective Effects of Terpenes

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

November 15, 2025

Study Completion Date

April 30, 2026

Conditions
PainAbuse, Drug
Interventions
DRUG

Low THC

Vaporized THC (5 mg)

DRUG

High THC

Vaporized THC (15 mg)

DRUG

Low Myrcene

Vaporized Myrcene (0.5 mg)

DRUG

High Myrcene

Vaporized Myrcene (12.0 mg)

DRUG

Low Beta-Caryophyllene

Vaporized Beta-Caryophyllene (0.5 mg)

DRUG

High Beta-Caryophyllene

Vaporized Beta-Caryophyllene (7.5 mg)

DRUG

Placebo

Vaporized Placebo

Trial Locations (1)

90095

University of California, Los Angeles, Los Angeles

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of California, Los Angeles

OTHER